Siegfried Holding AG - SGFEF

Siegfried Holding AG engages in the life sciences business worldwide. It develops and produces active pharmaceutical ingredients (APIs) and intermediates, as well as finished dosage forms, including solid oral dosage forms, and sterile and aseptic filling liquid dosage forms. The company offers custom API and intermediate synthesis services, including process and chemical development, analytical development, pilot manufacturing and scale up, and commercial manufacturing; and contract development and manufacturing services, such as pharmaceutical and analytical development, scale up and clinical trial material production, process and analytical transfer, and commercial manufacturing and packaging. It also provides APIs and controlled substances focusing on anesthetics, pain/addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition. The company’s product portfolio for multi clients comprises opiate derivatives used in strong pain killers primarily for cancer therapy, as well as APIs that include methadone and nicotine used in addiction therapy. In addition, it licenses solid and sterile products; assembles registration dossiers; and offers a common technical document for various products. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.